New research published in Annals of Internal Medicine explores the possible benefits and limitations of using computer assistance, or artificial intelligence, in detecting lesions and cancer during colonoscopy. An editorial accompanying these articles highlights that the current gap between randomized controlled trial performance and real-world performance likely reflects both differences in clinician behavior outside of trials and the complexity of real-world clinical environments.